THE US Food and Drug Administration has approved Rydapt (midostaurin) from Novartis for the treatment of adults with newly diagnosed acute myeloid leukaemia (AML) with a specific genetic mutation called FLT3.
THE Therapeutic Goods Administration (TGA) is today launching a public consultation to explore the possibility of expanding the regulation of unapproved medicinal cannabis products, a move welcomed by the Pharmaceutical Society of Australia.
AMCAL has presented a $200,000 donation to charity partner RizeUp Australia at its recent 10th Anniversary Gala Ball.
WESTERN Australia is the latest state to move towards greater access to care from community pharmacists, with WA Minister for Health Meredith Hammat announcing 17 common acute and chronic conditions that will soon be treatable by qualified pharmacists.
Notifications
